FDA Warning Letter to East CK Trading Inc.

The FDA issued a warning letter to East CK Trading Inc. for significant violations of the Foreign Supplier Verification Program (FSVP) regulation. The company failed to develop and maintain an FSVP for imported foods, leading to potential refusal of admission and detention without physical examination.

FDA Warning Letter to Dynamic Stem Cell Therapy

The FDA issued a warning letter to Dynamic Stem Cell Therapy for misbranding an umbilical cord-derived stem cell product. The product is considered an unapproved new drug and an unlicensed biological product, violating the Federal Food, Drug, and Cosmetic Act. The FDA's review found claims on the company's website indicating the product is intended to diagnose, cure, mitigate, treat, or prevent disease.

FDA Warning Letter to AQ USA Inc. for Drug Manufacturing Violations

The FDA issued a warning letter to AQ USA Inc., d.b.a Ross Healthcare Inc., for significant Current Good Manufacturing Practice (CGMP) violations at its drug manufacturing facility in Lynden, Washington. The violations include inadequate laboratory testing for microbial contamination and failure to establish appropriate specifications for drug products.

FDA Warning Letter to A. Nelson & Co. Ltd

The FDA issued a warning letter to A. Nelson & Co. Ltd. for significant violations of Current Good Manufacturing Practice (CGMP) regulations, including inadequate microbial testing and unsupported expiration date extensions. The company's drug products were found to be adulterated.

HHS OIG Report: Alaska Missed Foster Care Opportunities for Native Children

The HHS Office of Inspector General issued a report finding that Alaska missed opportunities to protect American Indian and Alaska Native children missing from foster care. The report details failures in notification, follow-up actions, sex trafficking assessments, caseworker visits, and tribal communication, recommending improvements supported by ACF.

HHS OIG: Sarasota Memorial Hospital Medicare Overpayments Total $12.1 Million

The HHS Office of Inspector General (OIG) found that Sarasota Memorial Hospital received at least $12.1 million in Medicare overpayments between January 1, 2020, and December 31, 2021. The OIG recommended the hospital refund the overpaid amount and implement additional training.

Prominent lawyer convicted of tax evasion, mortgage fraud

Prominent lawyer convicted of tax evasion, mortgage fraud

Solonitsyn et al v. Rubio et al - Mandamus Case Filing

A new civil case, Solonitsyn et al v. Rubio et al, was filed on February 23, 2026, in the U.S. District Court for the Northern District of California. The case is based on a Federal Question and seeks a Writ of Mandamus. Recent filings include the petition and proposed summons.

FTC v. Walmart Inc. - Civil Case Filing

The Federal Trade Commission (FTC) and other agencies have filed a civil case against Walmart Inc. The case, filed on February 26, 2026, seeks permanent injunctions, monetary judgments, and civil penalties. This action initiates a significant legal challenge concerning Walmart's business practices.

Opioid Use Disorder Medication Treatment Correction

The Department of Health and Human Services has issued a correction to its rule on Medications for the Treatment of Opioid Use Disorder. This correction clarifies specific provisions within the existing regulation, ensuring accurate implementation and adherence.